Skip to the note
Field notes The care

Good questions belong in the visit.

Does asking questions get in the way?

Use the questions that match the decision in front of you.

Myth to check

Once the form is done, the questions are over.

Rethink that tirzepatide assumption

Questions are part of care. The medical boards’ guidance requires access to the person providing your care so you can raise further questions.

Make room for answers before committing

A health-history form records your illnesses and medicines. You still need a way to ask your own questions.

Ask how questions reach the person treating you and how follow-up is handled. Write down the product and care terms you are given.

Questions and answers

Does the first visit have to use video?

Sometimes you can send information for a doctor to review later instead of speaking live on video. The medical boards’ guidance allows this only if it provides the same medical checks as a visit in a room. State rules differ as of 26 September 2026.

Who is actually making the care decision?

Ask for the name and job title of the person deciding whether to prescribe. The boards’ guidance says their name and qualifications need to be made clear. That person may be a doctor, a nurse trained to prescribe, or a licensed medical professional called a physician assistant. What they may prescribe depends on state rules.

Which pharmacy makes or sends the medicine?

Get the full name of the pharmacy. FDA, the US medicine regulator, notes that people ordering compounded medicines online may not know who prepared them. That name lets you check the state pharmacy record.

Will the assessment need blood tests?

It depends on your health and the medical checks needed. The boards’ guidance requires the person treating you to arrange any needed tests or send you to someone who can arrange them.

Does the care fee include the drug?

Ask for a written total. In the service offers checked in September 2026, medicine cost extra on top of the care membership. These were advertisements from a few services. Ask what you pay after the first offer ends and how to cancel.

What needs discussing if treatment stops?

Ask for a plan for stopping, changing treatment, or losing coverage. In the SURMOUNT-4 trial, people switched to a dummy shot regained weight on average. That is a trial finding, not a rule that every person must stay on treatment forever.

Evidence behind this note

Evidence

Care includes answers to your questions

The boards’ guidance requires a route for patients to raise further questions about their care, including when the care is online.

Federation of State Medical Boards

Read the boards’ prescribing guidance

Evidence

Stopping was tested, not assumed

SURMOUNT-4 compared continued tirzepatide with a switch to a dummy shot after an initial treatment period.

JAMA

Read the stopping-trial summary